Kaar, Stephen J. http://orcid.org/0000-0003-0194-0806
Angelescu, Ilinca
Nour, Matthew M.
Marques, Tiago Reis
Sharman, Alice
Sajjala, Anil
Hutchison, John
McGuire, Philip
Large, Charles
Howes, Oliver D.
Funding for this research was provided by:
Innovate UK (314170)
Article History
Received: 26 November 2021
Accepted: 16 August 2022
First Online: 12 September 2022
Declarations
:
: This study was provided with funding from Innovate UK, and Autifony Ltd. SK received travel expenses to attend a scientific meeting arranged by Autifony. IA has nothing to disclose. MN has nothing to disclose. TRM has received honoraria for speaking and chairing engagements from Lundbeck, Janssen, and Astellas. PM has nothing to disclose. OH is a part-time employee of H. Lundbeck A/S and has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Angellini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Jansenn, Lundbeck, Neurocrine, Otsuka, Sunovion, Rand, Recordati, Roche and Viatris/ Mylan. Dr Howes has a patent for the use of dopaminergic imaging. AS, AS, JH and CL are employees and shareholders in Autifony Ltd.